Keyword Connections

dyslipidemia

Journals

21

1 Nature communications

2 phytotherapy research : ptr

3 PloS one

4 ACS omega

5 International journal of environmental research and public health

6 Chemistry & biodiversity

7 Acta psychologica

8 International journal for quality in health care : journal of the International Society for Quality in Health Care

9 BMJ

10 clinical therapeutics

11 Advances in therapy

12 expert opinion on therapeutic targets

13 lipids in health and disease

14 african health sciences

15 metabolism: clinical and experimental

16 pediatric nephrology (berlin, germany)

17 zhonghua nei ke za zhi

18 the annals of thoracic surgery

19 science (new york, ny)

20 proceedings symposium on computer architecture and high performance computing

21 zhonghua shi yan he lin chuang bing du xue za zhi = zhonghua shiyan he linchuang bingduxue zazhi = chinese journal of experimental and clinical virology

Research Groups

0

No Research Group Connected

Bibliographies

93

1 Decrease in HDL-C is Associated with Age and Household Income in Adults from the Korean National Health and Nutrition Examination Survey 2017: Correlation Analysis of Low HDL-C and Poverty.

2 Curcumin-3,4-Dichloro Phenyl Pyrazole (CDPP) overcomes curcumin's low bioavailability, inhibits adipogenesis and ameliorates dyslipidemia by activating reverse cholesterol transport.

3 Efficient irregular wavefront propagation algorithms on Intel Xeon Phi.

4 Ultrastructural and functional fate of recycled vesicles in hippocampal synapses.

5 'Are We Not Human?' Stories of Stigma, Disability and HIV from Lusaka, Zambia and Their Implications for Access to Health Services.

6 Working memory capacity and dual-task interference in picture naming.

7 [Comparative study on the effect of highly active antiretroviral therapy (HAART) in patients with HIV infection acquired by blood transfusion and paid plasma donation].

8 Down-regulated of SREBP-1 in circulating leukocyte is a risk factor for atherosclerosis: a case control study.

9 The neural basis of combinatory syntax and semantics.

10 Residual SYNTAX Score after Advanced Hybrid Robotic Totally Endoscopic Coronary Revascularization.

11 Management of dyslipidemia in pediatric renal transplant recipients.

12 [China cholesterol education program (CCEP) expert advice for the management of dyslipidaemias to reduce cardiovascular risk (2019)].

13 Effects of gender, age and treatment duration on lipid profile and renal function indices in diabetic patients attending a teaching hospital in South-Western Nigeria.

14 Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care

15 rutaecarpine exhibits anti-diabetic potential in high fat diet–multiple low dose streptozotocin induced type 2 diabetic mice and in vitro by modulating hepatic glucose homeostasis

16 the relationship between dyslipidemia and disease activity in iranian population with systemic lupus erythematosus

17 influência do modo de preparo de alimentos na prevenção da aterosclerose the influence of food preparation methods on atherosclerosis prevention

18 aerobic exercise training selectively changes oxysterol levels and metabolism reducing cholesterol accumulation in the aorta of dyslipidemic mice

19 drug lag for cardiovascular drug approvals in india compared with the us and eu approvals

20 metabolic syndrome among type-2 diabetic patients in benghazi-libya: a pilot study

21 assessment of lipid lowering effect of nepeta hindostana herb extract in experimentally induced dyslipidemia

22 primary prevention of cardiovascular disease

23 atherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in southeast nigeria

24 lipitension : interplay between dyslipidemia and hypertension

25 the use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia

26 fatores de risco para aterosclerose em crianças e adolescentes com história familiar de doença arterial coronariana prematura risk factors for atherosclerosis in children and adolescents with family history of premature coronary artery disease

27 association between eight functional polymorphisms and haplotypes in the cholesterol ester transfer protein (cetp) gene and dyslipidemia in national minority adults in the far west region of china

28 association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents

29 Dissecting the role of insulin resistance in the metabolic syndrome

30 Viscosol Treatment Ameliorates Insulin-Mediated Regulation of Dyslipidemia, Hepatic Steatosis, and Lipid Metabolism by Targeting PTP1B in Type-2 Diabetic Mice Model.

31 Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease.

32 Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study

33 Impact of dyslipidemia on cardiovascular risk stratification of hypertensive patients and association of lipid profile with other cardiovascular risk factors: results from the ICEBERG study

34 Genes associated with free fatty acid levels and dyslipidemia in type 2 diabetes patients

35 DYSLIPIDEMIA AS A FACTOR FOR PROGRESSION OF RENAL OSTEODYSTROPHY AND CORONARY HEART DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON PERITONEAL DIALYSIS

36 Anti diabetic and anti dyslipidemia activities of Cleome gynandra in alloxan induced diabetic rats

37 Risk factors for the metabolic syndrome components of hypertension, diabetes mellitus, and dyslipidemia after living donor liver transplantation.

38 Whole barley prevents obesity and dyslipidemia without the involvement of the gut microbiota in germ free C57BL/6J obese mice.

39 Getting to an ImprOved Understanding of Low-Density Lipoprotein-Cholesterol and Dyslipidemia Management (GOULD): Methods and baseline data of a registry of high cardiovascular risk patients in the United States: GOULD Registry Methods and Baseline Data

40 Analysis of a clinical case: Medical nutrition therapy in a newly diagnosed diabetes with obesity, hypertension and dyslipidemia. 1st part: The nutritional assessment

41 Cacao beans extract (Theobroma cacao L.) improve lipid profile but had no effect on blood nox concentration in dyslipidemia white male rat (Rattus norvegicus)

42 Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey, 2015.

43 A STUDY OF METABOLIC PARAMETERS IN NON DIABETIC PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE - IMPORTANCE OF DYSLIPIDEMIA.

44 Association of fetuin-a with dyslipidemia and insulin resistance in type-II diabetics of Pakistani population

45 Effect of insulin verses metformin on hyper-glycemia and dyslipidemia in type-ii diabetic patients

46 Autophagy protects peripheral blood mononuclear cells against inflammation, oxidative and nitrosative stress in diabetic dyslipidemia

47 Diabetic dyslipidemia with eruptive xanthoma

48 The efficacy of Nigella Sativa L extracts to reduce cardiovascular disease risk in diabetic dyslipidemia

49 An update on pharmacotherapies in diabetic dyslipidemia

50 New dual peroxisome proliferator activated receptor agonist - Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: Integrated analysis of the real world evidence

51 Association of variants rs7903146 and rs290487 of TCF7L2 gene with diabetic nephropathy and co-morbidities (hypertension and dyslipidemia) in type 2 diabetes mellitus

52 Curcumin combined with metformin decreases glycemia and dyslipidemia, and increases paraoxonase activity in diabetic rats

53 Prevalence of dyslipidemia associated with complications in diabetic patients: A nationwide study in Thailand

54 Relation of homocysteine with malondialdehyde and dyslipidemia in type 2 diabetic patients with coronary artery diseases

55 Diabetes Self-Management Education and Medical Nutrition Therapy: A Multisite Study Documenting the Efficacy of Registered Dietitian Nutritionist Interventions in the Management of Glycemic Control and Diabetic Dyslipidemia through Retrospective Chart Review

56 Future perspectives of the pharmacological management of diabetic dyslipidemia

57 Potential therapeutic effect of Moroccan propolis in hyperglycemia, dyslipidemia, and hepatorenal dysfunction in diabetic rats

58 Impact of glycaemia, dyslipidemia and anxiety level on oxidative stress in prediabetic and diabetic patients

59 A randomized controlled trial of a herbal compound for improving metabolic parameters in diabetic patients with uncontrolled dyslipidemia

60 The prevalence and risk factors associated with dyslipidemia in type 2 diabetic patients in the autonomous Region of Cantabria

61 The treatment of diabetic dyslipidemia based on pathophysiological mechanisms

62 Evaluation of the circulating betatrophin concentration and its possible correlations among diabetic patients with dyslipidemia

63 The APoE<sup>∗</sup>3-Leiden heterozygous glucokinase knockout mouse as novel translational disease model for type 2 diabetes, dyslipidemia, and diabetic atherosclerosis

64 A contemporary overview of PPARα/γ dual agonists for the management of diabetic dyslipidemia

65 Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: A place far from heaven

66 Pathogenesis and significance of diabetic dyslipidemia

67 Prevalence of dyslipidemia among the diabetic patients in southern Bangladesh: A cross-sectional study

68 Prevalence of dyslipidemia in adult Indian diabetic patients: A cross sectional study (SOLID)

69 Achievement of the low-density lipoprotein cholesterol goal among patients with dyslipidemia in South Korea.

70 Rice bran attenuated obesity via alleviating dyslipidemia, browning of white adipocytes and modulating gut microbiota in high-fat diet-induced obese mice.

71 Maternal hypercholesterolemia programs dyslipidemia in adult male mouse progeny.

72 Dyslipidemia among HIV-infected Patients with Tuberculosis Taking Once-daily Nonnucleoside Reverse-Transcriptase Inhibitor–Based Antiretroviral Therapy in India

73 dyslipidemia and breast cancer

74 comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: a randomized, open-label, multicenter clinical trial in indian population

75 low hdl, the most common type of dyslipidemia in birjand studies: it is necessary to study: letter to editor

76 extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters

77 correlation between traditional chinese medicine constitution and dyslipidemia: a systematic review and meta-analysis

78 simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial

79 nutraceuticals and bioactive components from fish for dyslipidemia and cardiovascular risk reduction

80 associations of fatty liver disease with hypertension, diabetes, and dyslipidemia: comparison between alcoholic and nonalcoholic steatohepatitis

81 dyslipidemia in women: etiology and management

82 risco e assistência à dislipidemia no climatério risk factors and assistance to dyslipidemia in climacteric women

83 treatment of patients with severe dyslipidemia in real clinical practice

84 role of complementary and alternative medicine in controlling dyslipidemia

85 management of dyslipidemia in renal disease and transplantation

86 dislipidemia en el sÍndrome de preemclapsia / dyslipidemia in preeclampsia syndrome

87 drugs involved in dyslipidemia and obesity treatment: focus on adipose tissue

88 screening for dyslipidemia and expedience of statin therapy for the citizens of transcarpathia valley regions with overweight and obesity

89 fenugreek seed extract inhibit fat accumulation and ameliorates dyslipidemia in high fat diet-induced obese rats

90 the correlation of dyslipidemia with the extent of coronary artery disease in the multiethnic study of atherosclerosis

91 jtt-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats

92 simvastatin/fenofibrate combination in the treatment of dyslipidemia: current evidence

93 Drugs for Dyslipidemias